By working closely with VAS, we aim to expand our footprint in the Kingdom, support our partners, and better serve customers with advanced cyber and fraud intelligence capabilities tailored to the evolving local threat landscape.”.
The research demonstrates that Vascarta's proprietary transdermal curcumin formulation (VAS-101) reduces oxidative stress and improves cardiac mitochondrial bioenergetics in a humanized mouse model of sickle cell disease (SCD).